MedPharm
MedPharm operates a hybrid business model, with a CRO business focusing on pharmaceutical development and a patent portfolio of topical and transdermal delivery systems. Its expertise is in topical (skin, nail, eye, nose, lungs and other mucosal membranes) and transdermal products.
MedPharm is a specialist pharmaceutical development company with expertise in topical (skin, nail, eye, nose, lungs and other mucosal membranes) and transdermal product development.
Projects range from simple feasibility tests, formulation design and testing, through to preparation of GMP clinical supplies for Phase I/II trials with transfer through to commercial manufacturing sites. MedPharm operates a hybrid business model, with a CRO business focusing on pharmaceutical development and a patent portfolio of novel topical and transdermal drug delivery systems. These systems include MedSpray®, MedTherm™ and most recently AquaRMed™, all of which are available under licence to its clients. MedPharm has produced these innovations by exploiting internal product development expertise.
Established in 1999 as a spin-out from Kings College London, MedPharm has 120 employees and facilities in Guildford, UK and Durham, NC, US. It is privately held.
Articles by MedPharm
